Skip to main content
BrainCited

Alpha-GPC per Neurotransmitter Imbalance

B

Alpha-GPC provides 40% choline bioavailability, directly supporting acetylcholine synthesis — the primary neurotransmitter for learning and memory. Clinical studies in elderly patients show improvements in cognitive function scores.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dalpha\u002Dgpc\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

In sintesi

Alpha-GPC provides 40% choline bioavailability, directly supporting acetylcholine synthesis — the primary neurotransmitter for learning and memory. Clinical studies in elderly patients show improvements in cognitive function scores.

Key Study Findings

Randomized Controlled Trial
Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized …
Dose: None vs: None Outcome: Cognitive decline Effetto: None None

Popolazione: Alzheimer's disease patients

Review
Choline supplements: An update.
Dose: alpha-GPC, choline bitartrate, lecithin, citicoline vs: None Outcome: Cognitive and muscular performance Effetto: None None

Popolazione: General population (review)

Key Statistics

10

Studi

800

Partecipanti

Positive

B

Grado

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
300-600 mg/day
cognitivesupport:
600-1,200 mg/day

Limite massimo: Not established; well-tolerated up to 1,200 mg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
None -- Positive --
alpha-GPC, choline bitartrate, lecithin, citicoline -- Positive --

Momento migliore per l'assunzione: Morning or split dose; with or without food

Safety & Side Effects

Effetti collaterali segnalati

  • Headache
  • Insomnia
  • Dizziness
  • Gastrointestinal discomfort
  • Fishy body odor at high doses (TMAO conversion)

Interazioni note

  • Anticholinergic medications (opposes Alpha-GPC effects)
  • Cholinesterase inhibitors (additive cholinergic effects)
  • Scopolamine (opposes cholinergic effects)

Livello di assunzione massimo tollerabile: Not established; well-tolerated up to 1,200 mg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Alpha-GPC help with Neurotransmitter Imbalance?
Based on 10 studies with 800 participants, there is moderate evidence from clinical studies that Alpha-GPC may support Neurotransmitter Imbalance management. Our evidence grade is B (Good Evidence).
How much Alpha-GPC should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 300-600 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Alpha-GPC?
Reported side effects may include Headache, Insomnia, Dizziness, Gastrointestinal discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Alpha-GPC and Neurotransmitter Imbalance?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Related Evidence

Altri ingredienti per Neurotransmitter Imbalance

Alpha-GPC per altre condizioni

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.